• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动负荷与中风风险:一项系统评价和剂量反应荟萃分析。

Atrial fibrillation burden and the risk of stroke: A systematic review and dose-response meta-analysis.

作者信息

Yang Sheng-Yi, Huang Min, Wang Ai-Lian, Ge Ge, Ma Mi, Zhi Hong, Wang Li-Na

机构信息

Department of Epidemiology and Biostatistics, Southeast University, Nanjing 210009, Jiangsu Province, China.

Yaohua Community Healthcare Center, Nanjing 210046, Jiangsu Province, China.

出版信息

World J Clin Cases. 2022 Jan 21;10(3):939-953. doi: 10.12998/wjcc.v10.i3.939.

DOI:10.12998/wjcc.v10.i3.939
PMID:35127908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8790433/
Abstract

BACKGROUND

The increased stroke risk associated with atrial fibrillation (AF) burden exceeding 5 min is a matter of debate. In addition, the potential linear or nonlinear relationship between AF burden and stroke risk has been largely unexplored.

AIM

To determine the association between AF burden > 5 min and the increased risk of stroke and explore the potential dose-response relationship between these two factors.

METHODS

Sixteen studies from six databases with 53141 subjects (mean age 65 years) were included. Fifteen studies were observational studies, and one was a randomized controlled trial study. The potential nonlinear dose-response association was characterized using a restricted cubic splines regression model. AF burden for each 1 h and 2 h was associated with an increased risk of stroke. Trial sequential analysis with a random-effect model was used to evaluate the robustness of the evidence from the included 16 studies.

RESULTS

AF burden > 5 min was associated with an increased risk of clinical AF [adjusted risk ratio (RR) = 4.18, 95% confidence interval (CI): 2.26-7.74]. However, no association was found with an increased risk of all-cause mortality (adjusted RR = 1.55, 95%CI: 0.87-2.75). Patients with AF burden > 5 min had an increased risk of stroke (adjusted RR = 2.49, 95%CI: 1.79-3.47). Moreover, a dose-response analysis showed that the increased stroke risk was paralleled by an increase in AF burden at a rate of 2.0% hour ( = 0.656, RR = 1.02, 95%CI: 1.01-1.03). Trial sequential analysis provided robust evidence of the association between AF burden > 5 min and an increased risk of stroke.

CONCLUSION

AF burden was a significant risk factor for clinical AF and future stroke. A significant linear association was documented between increased AF burden and risk of future stroke.

摘要

背景

房颤(AF)负荷超过5分钟与中风风险增加之间的关系存在争议。此外,AF负荷与中风风险之间潜在的线性或非线性关系在很大程度上尚未得到探索。

目的

确定AF负荷>5分钟与中风风险增加之间的关联,并探讨这两个因素之间潜在的剂量反应关系。

方法

纳入了来自六个数据库的16项研究,共53141名受试者(平均年龄65岁)。15项研究为观察性研究,1项为随机对照试验研究。使用受限立方样条回归模型来描述潜在的非线性剂量反应关联。每1小时和2小时的AF负荷与中风风险增加相关。采用随机效应模型的试验序贯分析来评估纳入的16项研究证据的稳健性。

结果

AF负荷>5分钟与临床房颤风险增加相关[调整风险比(RR)=4.18,95%置信区间(CI):2.26-7.74]。然而,未发现与全因死亡率风险增加相关(调整RR=1.55,95%CI:0.87-2.75)。AF负荷>5分钟的患者中风风险增加(调整RR=2.49,95%CI:1.79-3.47)。此外,剂量反应分析表明,中风风险增加与AF负荷以每小时2.0%的速率增加平行( =0.656,RR=1.02,95%CI:1.01-1.03)。试验序贯分析为AF负荷>5分钟与中风风险增加之间的关联提供了有力证据。

结论

AF负荷是临床房颤和未来中风的重要危险因素。记录到AF负荷增加与未来中风风险之间存在显著的线性关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/2e4042e875c9/WJCC-10-939-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/644c11d6bf66/WJCC-10-939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/58bdb020e25c/WJCC-10-939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/8191b683d799/WJCC-10-939-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/51a28b8b226a/WJCC-10-939-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/261969bc6b75/WJCC-10-939-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/2e4042e875c9/WJCC-10-939-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/644c11d6bf66/WJCC-10-939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/58bdb020e25c/WJCC-10-939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/8191b683d799/WJCC-10-939-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/51a28b8b226a/WJCC-10-939-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/261969bc6b75/WJCC-10-939-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/904c/8790433/2e4042e875c9/WJCC-10-939-g006.jpg

相似文献

1
Atrial fibrillation burden and the risk of stroke: A systematic review and dose-response meta-analysis.心房颤动负荷与中风风险:一项系统评价和剂量反应荟萃分析。
World J Clin Cases. 2022 Jan 21;10(3):939-953. doi: 10.12998/wjcc.v10.i3.939.
2
The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies.维生素 D 与心房颤动风险的关系:观察性研究的剂量反应分析。
Nutr J. 2019 Nov 14;18(1):73. doi: 10.1186/s12937-019-0485-8.
3
Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis.ω-3 脂肪酸治疗与心血管结局试验中心房颤动的关系:系统评价和荟萃分析。
Cardiovasc Drugs Ther. 2021 Aug;35(4):793-800. doi: 10.1007/s10557-021-07204-z. Epub 2021 May 31.
4
Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.房颤导管消融术与死亡率和卒中的关联:系统评价和荟萃分析。
Int J Cardiol. 2018 Sep 1;266:136-142. doi: 10.1016/j.ijcard.2018.03.068.
5
Alcohol consumption and atrial fibrillation risk: An updated dose-response meta-analysis of over 10 million participants.饮酒与房颤风险:对超过1000万参与者的最新剂量反应荟萃分析。
Front Cardiovasc Med. 2022 Sep 30;9:979982. doi: 10.3389/fcvm.2022.979982. eCollection 2022.
6
Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.地高辛治疗心房颤动和心房扑动:随机临床试验的系统评价与荟萃分析和试验序贯分析。
PLoS One. 2018 Mar 8;13(3):e0193924. doi: 10.1371/journal.pone.0193924. eCollection 2018.
7
Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.口服抗凝药物在房颤合并 CKD 患者中的应用:一项系统评价和两两网络荟萃分析。
Am J Kidney Dis. 2021 Nov;78(5):678-689.e1. doi: 10.1053/j.ajkd.2021.02.328. Epub 2021 Apr 16.
8
Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.房颤的外科消融治疗:随机对照试验的系统评价和荟萃分析。
Europace. 2018 Sep 1;20(9):1442-1450. doi: 10.1093/europace/eux336.
9
Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).设备检测到的心房颤动与中风风险:对来自SOS AF项目(基于植入式设备的心房颤动信息的中风预防策略)的10000多名患者的分析。
Eur Heart J. 2014 Feb;35(8):508-16. doi: 10.1093/eurheartj/eht491. Epub 2013 Dec 11.
10
Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.起搏器检出的心房颤动负荷与缺血性卒中和血栓栓塞事件风险:一项队列研究。
Heart Lung. 2020 Jan-Feb;49(1):66-72. doi: 10.1016/j.hrtlng.2019.07.007. Epub 2019 Jul 31.

引用本文的文献

1
Contemporary Practices for Management of Subclinical Atrial Fibrillation.亚临床房颤管理的当代实践
J Clin Med. 2025 Jul 23;14(15):5222. doi: 10.3390/jcm14155222.
2
Understanding Reasons for Oral Anticoagulation Nonprescription in Atrial Fibrillation Using Large Language Models.使用大语言模型理解心房颤动患者未接受口服抗凝治疗的原因
J Am Heart Assoc. 2025 Apr;14(7):e040419. doi: 10.1161/JAHA.124.040419. Epub 2025 Mar 27.
3
Impact of initial high sensitivity C-reactive protein on outcomes in nonvalvular atrial fibrillation: an observational study.

本文引用的文献

1
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.21 世纪心房颤动的流行病学:新方法与新见解。
Circ Res. 2020 Jun 19;127(1):4-20. doi: 10.1161/CIRCRESAHA.120.316340. Epub 2020 Jun 18.
2
Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.严重急性呼吸综合征和中东呼吸综合征冠状病毒暴发后住院或 ICU 入住患者的长期临床结局:系统评价和荟萃分析。
J Rehabil Med. 2020 May 31;52(5):jrm00063. doi: 10.2340/16501977-2694.
3
初始高敏 C 反应蛋白对非瓣膜性心房颤动结局的影响:一项观察性研究。
Future Cardiol. 2024 Apr 25;20(5-6):295-303. doi: 10.1080/14796678.2024.2354110. Epub 2024 Jun 10.
4
Revitalizing brain perfusion: Unveiling advancements through rhythm control strategies in atrial fibrillation-A systematic review.恢复脑灌注:通过房颤节律控制策略揭示进展——一项系统综述
J Arrhythm. 2024 May 13;40(3):411-422. doi: 10.1002/joa3.13056. eCollection 2024 Jun.
5
Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care.再灌注治疗背景下急性缺血性卒中合并心房颤动的诊断与管理:优化治疗的见解与策略
J Cardiovasc Dev Dis. 2023 Nov 12;10(11):458. doi: 10.3390/jcdd10110458.
6
Ischemic stroke risk factors not included in the CHADS-VASC score in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者的 CHADS-VASC 评分中不包括缺血性脑卒中危险因素。
Arq Neuropsiquiatr. 2023 Aug;81(8):712-719. doi: 10.1055/s-0043-1771167. Epub 2023 Aug 11.
7
Dog ownership may promote cardiometabolic health in U.S. military veterans.养狗可能有助于改善美国退伍军人的心血管代谢健康。
Sci Rep. 2023 Jul 8;13(1):11075. doi: 10.1038/s41598-023-38038-4.
8
The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring.与24小时动态心电图监测相比,7天连续心电图贴片监测检测心律失常的效果更高。
J Arrhythm. 2023 May 8;39(3):422-429. doi: 10.1002/joa3.12865. eCollection 2023 Jun.
9
Assessment of the atrial fibrillation burden in Holter electrocardiogram recordings using artificial intelligence.使用人工智能评估动态心电图记录中的房颤负荷。
Cardiovasc Digit Health J. 2023 Jan 27;4(2):41-47. doi: 10.1016/j.cvdhj.2023.01.003. eCollection 2023 Apr.
10
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin.欧洲卒中组织(ESO)关于对不明原因的卒中或短暂性脑缺血发作后隐匿性心房颤动进行筛查的指南。
Eur Stroke J. 2022 Sep;7(3):VI. doi: 10.1177/23969873221099478. Epub 2022 Jun 3.
Atrial Fibrillation: JACC Council Perspectives.
心房颤动:美国心脏病学会理事会观点。
J Am Coll Cardiol. 2020 Apr 14;75(14):1689-1713. doi: 10.1016/j.jacc.2020.02.025.
4
Chili Consumption and Risk of Gastric Cancer: A Meta-Analysis.食用辣椒与胃癌风险:一项荟萃分析。
Nutr Cancer. 2021;73(1):45-54. doi: 10.1080/01635581.2020.1733625. Epub 2020 Apr 2.
5
Stroke Risk as a Function of Atrial Fibrillation Duration and CHADS-VASc Score.房颤持续时间和 CHADS-VASc 评分与卒中风险的关系。
Circulation. 2019 Nov 12;140(20):1639-1646. doi: 10.1161/CIRCULATIONAHA.119.041303. Epub 2019 Sep 30.
6
Stroke and thromboembolism prevention in atrial fibrillation.心房颤动的卒中预防和血栓栓塞预防。
Heart. 2020 Jan;106(1):10-17. doi: 10.1136/heartjnl-2019-314898. Epub 2019 Sep 18.
7
Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.起搏器检出的心房颤动负荷与缺血性卒中和血栓栓塞事件风险:一项队列研究。
Heart Lung. 2020 Jan-Feb;49(1):66-72. doi: 10.1016/j.hrtlng.2019.07.007. Epub 2019 Jul 31.
8
Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project.在无房颤患者中心房高频事件与血栓栓塞:西伯明翰房颤项目。
Int J Cardiol. 2019 Oct 1;292:126-130. doi: 10.1016/j.ijcard.2019.04.055. Epub 2019 Apr 17.
9
Impact of atrial high-rate episodes on the risk of future stroke.心房高频事件对未来中风风险的影响。
J Cardiol. 2019 Aug;74(2):144-149. doi: 10.1016/j.jjcc.2019.01.006. Epub 2019 Feb 3.
10
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的聚焦更新:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会与胸外科医师协会合作报告
Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28.